Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Cancer gene prioritization for targeted resequencing using FitSNP scores.

Fieuw A, De Wilde B, Speleman F, Vandesompele J, De Preter K.

PLoS One. 2012;7(3):e31333. doi: 10.1371/journal.pone.0031333. Epub 2012 Mar 1.

2.

Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.

Wang J, Zhang Y, Shen X, Zhu J, Zhang L, Zou J, Guo Z.

Mol Biosyst. 2011 Apr;7(4):1158-66. doi: 10.1039/c0mb00211a. Epub 2011 Jan 28.

PMID:
21279201
3.

Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment.

Berglund EC, Lindqvist CM, Hayat S, Övernäs E, Henriksson N, Nordlund J, Wahlberg P, Forestier E, Lönnerholm G, Syvänen AC.

BMC Genomics. 2013 Dec 5;14:856. doi: 10.1186/1471-2164-14-856.

4.

Speeding disease gene discovery by sequence based candidate prioritization.

Adie EA, Adams RR, Evans KL, Porteous DJ, Pickard BS.

BMC Bioinformatics. 2005 Mar 14;6:55.

5.

Domain landscapes of somatic mutations in cancer.

Nehrt NL, Peterson TA, Park D, Kann MG.

BMC Genomics. 2012 Jun 18;13 Suppl 4:S9. doi: 10.1186/1471-2164-13-S4-S9.

6.

ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.

Tian R, Basu MK, Capriotti E.

Bioinformatics. 2014 Sep 1;30(17):i572-8. doi: 10.1093/bioinformatics/btu466.

7.

Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes.

Varley KE, Mitra RD.

Genome Res. 2008 Nov;18(11):1844-50. doi: 10.1101/gr.078204.108. Epub 2008 Oct 10.

8.

De novo discovery of mutated driver pathways in cancer.

Vandin F, Upfal E, Raphael BJ.

Genome Res. 2012 Feb;22(2):375-85. doi: 10.1101/gr.120477.111. Epub 2011 Jun 7.

9.

VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.

Jia P, Zhao Z.

PLoS Comput Biol. 2014 Feb 6;10(2):e1003460. doi: 10.1371/journal.pcbi.1003460. eCollection 2014 Feb.

10.

Prioritizing regions of candidate genes for efficient mutation screening.

Braun TA, Shankar SP, Davis S, O'Leary B, Scheetz TE, Clark AF, Sheffield VC, Casavant TL, Stone EM.

Hum Mutat. 2006 Feb;27(2):195-200.

PMID:
16395665
12.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

13.

Bioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.

Aouacheria A, Navratil V, Barthelaix A, Mouchiroud D, Gautier C.

BMC Genomics. 2006 Apr 26;7:94.

14.

A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes.

Dufke C, Schlipf N, Schüle R, Bonin M, Auer-Grumbach M, Stevanin G, Depienne C, Kassubek J, Klebe S, Klimpe S, Klopstock T, Otto S, Poths S, Seibel A, Stolze H, Gal A, Schöls L, Bauer P.

Neurogenetics. 2012 Aug;13(3):215-27. doi: 10.1007/s10048-012-0329-6. Epub 2012 May 3.

PMID:
22552817
15.

Molecular evolutionary analysis of cancer cell lines.

Zhang Y, Italia MJ, Auger KR, Halsey WS, Van Horn SF, Sathe GM, Magid-Slav M, Brown JR, Holbrook JD.

Mol Cancer Ther. 2010 Feb;9(2):279-91. doi: 10.1158/1535-7163.MCT-09-0508. Epub 2010 Feb 2.

16.

High-throughput resequencing of target-captured cDNA in cancer cells.

Ueno T, Yamashita Y, Soda M, Fukumura K, Ando M, Yamato A, Kawazu M, Choi YL, Mano H.

Cancer Sci. 2012 Jan;103(1):131-5. doi: 10.1111/j.1349-7006.2011.02105.x. Epub 2011 Oct 13.

17.

ProphNet: a generic prioritization method through propagation of information.

Martínez V, Cano C, Blanco A.

BMC Bioinformatics. 2014;15 Suppl 1:S5. doi: 10.1186/1471-2105-15-S1-S5. Epub 2014 Jan 10.

18.

Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.

Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, Lesueur F, Landi S, Tavtigian SV.

BMC Genet. 2009 Feb 17;10:5. doi: 10.1186/1471-2156-10-5.

19.

Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.

Duncavage EJ, Abel HJ, Szankasi P, Kelley TW, Pfeifer JD.

Mod Pathol. 2012 Jun;25(6):795-804. doi: 10.1038/modpathol.2012.29. Epub 2012 Mar 16.

20.

Global risk transformative prioritization for prostate cancer candidate genes in molecular networks.

Chen L, Tai J, Zhang L, Shang Y, Li X, Qu X, Li W, Miao Z, Jia X, Wang H, Li W, He W.

Mol Biosyst. 2011 Sep;7(9):2547-53. doi: 10.1039/c1mb05134b. Epub 2011 Jul 7.

PMID:
21735017

Supplemental Content

Support Center